Clinical Trials in Philadelphia

Showing 16681-16700 of 20,904 trials

Mobile App for Mood in Pregnancy (Ginger iO)

NCT02761720

The Mobile Mood Tracking App study is a small randomized trial of acceptability and usability of a mobile phone mood tracking application (mobile app) among women with depressed mood in pregnancy. The study will be assessing the perceived value and usability of this tool in pregnancy over eight weeks to test whether women using this app are more likely to receive assessments and treatments of depressed mood than women not using it.

Mood DisordersDepression

University of Pennsylvania72 participantsStarted Feb 2015

Philadelphia, Pennsylvania, United States

WITHDRAWNPhase 3< 1 mile

Olaparib Maintenance Treatment Versus Placebo in Patients With PSR Ovarian Cancer Who Are in CR or PR to Platinum-based Chemotherapy and Whose Tumours Carry sBRCAm or HRR-associated Genes Mutations

NCT02392676

Olaparib administered as monotherapy in the maintenance setting improves progression free survival compared to placebo in patients whose tumours carry loss of function (deleterious or suspected deleterious) somatic BRCA mutations or loss of function (deleterious or suspected deleterious) mutation in non-BRCA Homologous Recombination Repair (HRR) -associated genes who have a complete or partial response to platinum-based chemotherapy.

Platinum Sensitive Relapsed Ovarian Cancer

AstraZenecaStarted Jul 2016

Mobile, Alabama, United States • Phoenix, Arizona, United States • Los Angeles, California, United States +26 more locations

Mobile App for Mood in Pregnancy (Ginger iO)

Olaparib Maintenance Treatment Versus Placebo in Patients With PSR Ovarian Cancer Who Are in CR or PR to Platinum-based Chemotherapy and Whose Tumours Carry sBRCAm or HRR-associated Genes Mutations

Find Trials by Condition in Philadelphia

Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis

NBS10 (Also Known as AMR-001) Versus Placebo Post ST Segment Elevation Myocardial Infarction

A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma Gangrenosum

An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum

Erlotinib and Sorafenib in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

Project ABLE:Advancing Better Living for Elders

Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025

A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer

Efficacy and Safety of XRP0038/NV1FGF in Critical Limb Ischemia Patients With Skin Lesions

Transcatheter Aortic Valve Replacement System Pivotal Trial

A Dose-Optimization Study for the Initial Treatment of Dysplastic Barrett's Esophagus With trūFreeze™ Spray Cryotherapy

Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis

An Evaluation of Non-invasive ICP Monitoring in Patients Undergoing Invasive ICP Monitoring Via an External Ventricular Drainage (EVD) Device

A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)

Bipap Automatic Servo Ventilation (autoSV) Advanced in Central Apnea Patients

Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects

Safety, Efficacy and PK/PD of QGE031 vs. Placebo in Patients With Active Bullous Pemphigoid Despite Oral Steroid Treatment

BYM338 in Chronic Obstructive Pulmonary Disease (COPD) Patients With Cachexia